Cholangio ID

Free

1.1.6for iPhone

Boston Scientific

Developer

Dec 11, 2017

Update Date

Medical

Category

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

Cholangio ID Screenshots

iPhone

About Cholangio ID

The purpose of the App is to provide physician-to-physician communication in the event of a biliary emergency. Biliary obstruction in patients with cholangiocarcinoma can be life-threatening. Patients with bile duct drainage tubes, biliary stents, ERCP or other medical procedures on the biliary tree are at high risk for bacterial infection and may warrant admission to a hospital with treatment as a medical emergency.

Because cholangiocarcinoma is rare, emergency room and community doctors outside of your specialized treatment team may not be familiar with the management of specific complications that may arise. This App will provide medical personnel with information on how to contact your doctor(s) should it be necessary. If your doctors cannot be reached, it will direct medical personnel to specific guidelines for your treatment.

The App also delivers the latest news and research about cholangiocarcinoma and provides patients and caregivers with the ability to track relevant health information related to cholangiocarcinoma diagnosis and treatment.